Dosimetric predictors of esophageal toxicity after stereotactic body radiotherapy for central lung tumors

Radiotherapy and Oncology

Volumn 112, Issue 2, 2014, Pages 267-271

  Wu, Abraham J ^a   Williams, Eric ^a   Modh, Ankit ^a   Foster, Amanda ^a   Yorke, Ellen ^a   Rimner, Andreas ^a   Jackson, Andrew ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Central; Esophagitis; Esophagus; Hypofractionated; Lung; SBRT

Indexed keywords

ACUTE TOXICITY; ADULT; AGED; ARTICLE; DOSIMETRY; ESOPHAGUS INJURY; FEMALE; HISTOGRAM; HUMAN; LUNG TUMOR; MAJOR CLINICAL STUDY; MALE; RADIATION INJURY; STEREOTACTIC BODY RADIATION THERAPY; ADVERSE EFFECTS; CANCER STAGING; CARCINOMA, NON-SMALL-CELL LUNG; COHORT ANALYSIS; ESOPHAGITIS; ESOPHAGUS; LUNG NEOPLASMS; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RADIATION INJURIES; RADIATION RESPONSE; RADIOSURGERY; RISK FACTOR; STATISTICAL MODEL;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; COHORT STUDIES; ESOPHAGITIS; ESOPHAGUS; FEMALE; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RADIATION INJURIES; RADIOSURGERY; RISK FACTORS;

EID: 84911007768     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2014.07.001     Document Type: Article

References (23)

1. R. Timmerman, R. Paulus, J. Galvin, J. Michalski, W. Straube, and J. Bradley Stereotactic body radiation therapy for inoperable early stage lung cancer JAMA 303 2010 1070 1076
2. R. Timmerman, R. McGarry, C. Yiannoutsos, L. Papiez, K. Tudor, and J. DeLuca Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer J Clin Oncol 24 2006 4833 4839
3. A. Bezjak Seamless Phase I/II Study of Stereotactic Lung Radiotherapy (SBRT) for Early Stage, Centrally Located, Non-Small Cell Lung Cancer (NSCLC) in Medically Inoperable Patients RTOG 2008 http://clinicaltrials.gov/show/NCT00750269
4. J.Y. Chang, P.A. Balter, L. Dong, Q. Yang, Z. Liao, and M. Jeter Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer Int J Radiat Oncol Biol Phys 72 2008 967 971
5. B.P. Rowe, D.J. Boffa, L.D. Wilson, A.W. Kim, F.C. Detterbeck, and R.H. Decker Stereotactic body radiotherapy for central lung tumors J Thorac Oncol 7 2012 1394 1399
6. S. Senthi, C.J. Haasbeek, B.J. Slotman, and S. Senan Outcomes of stereotactic ablative radiotherapy for central lung tumours: a systematic review Radiother Oncol 106 2013 276 282
7. C.J. Haasbeek, F.J. Lagerwaard, B.J. Slotman, and S. Senan Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer J Thorac Oncol 6 2011 2036 2043
8. Nuyttens JJ, van der Voort van Zyp NC, Praag J, Aluwini S, van Klaveren RJ, Verhoef C, et al. Outcome of four-dimensional stereotactic radiotherapy for centrally located lung tumors. Radiother Oncol 2012; 102: 383-7.
9. M. Werner-Wasik, E. Yorke, J. Deasy, J. Nam, and L.B. Marks Radiation dose-volume effects in the esophagus Int J Radiat Oncol Biol Phys 76 2010 S86 S93
10. J.J. Cuaron, E.D. Yorke, A. Foster, M. Hsu, Z. Zhang, and F. Liu Stereotactic body radiation therapy for primary lung cancers >3 centimeters J Thorac Oncol 8 2013 1396 1401
11. J.O. Deasy, S.M. Bentzen, A. Jackson, R.K. Ten Haken, E.D. Yorke, and L.S. Constine Improving normal tissue complication probability models: the need to adopt a "data-pooling" culture Int J Radiat Oncol Biol Phys 76 2010 S151 S154
12. A. Jackson, L.B. Marks, S.M. Bentzen, A. Eisbruch, E.D. Yorke, and R.K. Ten Haken The lessons of QUANTEC: recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome Int J Radiat Oncol Biol Phys 76 2010 S155 S160
13. A. Jackson, E.D. Yorke, and K.E. Rosenzweig The atlas of complication incidence: a proposal for a new standard for reporting the results of radiotherapy protocols Semin Radiat Oncol 16 2006 260 268
14. B.W. Cox, A. Jackson, M. Hunt, M. Bilsky, and Y. Yamada Esophageal toxicity from high-dose, single-fraction paraspinal stereotactic radiosurgery Int J Radiat Oncol Biol Phys 83 2012 e661 e667
15. D.A. Palma, S. Senan, C. Oberije, J. Belderbos, N.R. de Dios, and J.D. Bradley Predicting esophagitis after chemoradiation therapy for non-small cell lung cancer: an individual patient data meta-analysis Int J Radiat Oncol Biol Phys 87 2013 690 696
16. Q.T. Le, B.W. Loo, A. Ho, C. Cotrutz, A.C. Koong, and H. Wakelee Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors J Thorac Oncol 1 2006 802 809
17. R. Onimaru, H. Shirato, S. Shimizu, K. Kitamura, B. Xu, and S. Fukumoto Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers Int J Radiat Oncol Biol Phys 56 2003 126 135
18. J.M. Brown, D.J. Carlson, and D.J. Brenner The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved? Int J Radiat Oncol Biol Phys 88 2014 254 262
19. C. Park, L. Papiez, S. Zhang, M. Story, and R.D. Timmerman Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy Int J Radiat Oncol Biol Phys 70 2008 847 852
20. M. Guckenberger, R.J. Klement, M. Allgauer, S. Appold, K. Dieckmann, and I. Ernst Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer Radiother Oncol 109 2013 13 20
21. A.E. Scheenstra, M.M. Rossi, J.S. Belderbos, E.M. Damen, J.V. Lebesque, and J.J. Sonke Alpha/beta ratio for normal lung tissue as estimated from lung cancer patients treated with stereotactic body and conventionally fractionated radiation therapy Int J Radiat Oncol Biol Phys 88 2014 224 228
22. S.H. Benedict, K.M. Yenice, D. Followill, J.M. Galvin, W. Hinson, and B. Kavanagh Stereotactic body radiation therapy: the report of AAPM Task Group 101 Med Phys 37 2010 4078
23. J.A. Abelson, J.D. Murphy, B.W. Loo Jr., D.T. Chang, M.E. Daly, and E.A. Wiegner Esophageal tolerance to high-dose stereotactic ablative radiotherapy Dis Esophagus 25 2012 623 629